Psychoneurobiology Research and Personalized Treatment of Schizophrenia

Schizophrenia is a common disease characterized by psychotic symptoms (e.g., delusion, hallucinations, blunted affect) and disturbances of cognitive function (e.g., memory, abstraction, attention). If not treated properly, patients may experience serious consequences in terms of social function. Muc...

Full description

Saved in:
Bibliographic Details
Other Authors: Sumiyoshi, Tomiki (Editor)
Format: Book Chapter
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
Subjects:
Online Access:Get Fullteks
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 03572naaaa2200961uu 4500
001 doab_20_500_12854_78772
005 20220224
020 |a books978-3-0365-2858-8 
020 |a 9783036528588 
020 |a 9783036528595 
024 7 |a 10.3390/books978-3-0365-2858-8  |c doi 
041 0 |a English 
042 |a dc 
072 7 |a M  |2 bicssc 
100 1 |a Sumiyoshi, Tomiki  |4 edt 
700 1 |a Sumiyoshi, Tomiki  |4 oth 
245 1 0 |a Psychoneurobiology Research and Personalized Treatment of Schizophrenia 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2022 
300 |a 1 electronic resource (133 p.) 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Schizophrenia is a common disease characterized by psychotic symptoms (e.g., delusion, hallucinations, blunted affect) and disturbances of cognitive function (e.g., memory, abstraction, attention). If not treated properly, patients may experience serious consequences in terms of social function. Much endeavor in several disciplines of medical science has been made to overcome the paucity of effective treatments for unmet needs, including cognitive impairment associated with schizophrenia.This Book, contributed by experts from various regions of the globe, provides up-to-date information to facilitate the development of personal therapeutics for this enigmatic illness. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a first-episode psychosis 
653 |a metacognitive training 
653 |a cognitive insight 
653 |a sessions 
653 |a experiment 
653 |a magnetic resonance imaging 
653 |a schizophrenia 
653 |a schizotypal disorder 
653 |a gyrification 
653 |a superior temporal gyrus 
653 |a neurodevelopment 
653 |a cannabis 
653 |a proteomics 
653 |a olfactory neuroepithelium 
653 |a metabolism 
653 |a RNA 
653 |a ZNF326 
653 |a MTREX 
653 |a antipsychotics 
653 |a body mass index 
653 |a weight gain 
653 |a metabolic syndrome 
653 |a serotonin 
653 |a genes 
653 |a pharmacogenetics 
653 |a mental disorders 
653 |a developmental disorders 
653 |a social cognition 
653 |a social function 
653 |a facial expression recognition 
653 |a test battery 
653 |a quality of life 
653 |a systematic review 
653 |a needs survey 
653 |a neuromodulation 
653 |a transcranial direct current stimulation (tDCS) 
653 |a superior temporal sulcus 
653 |a P300 
653 |a event-related potentials 
653 |a clinical high-risk 
653 |a psychosis 
653 |a at risk mental state 
653 |a cognition 
653 |a latency 
653 |a microglia 
653 |a synaptic pruning 
653 |a complement 
653 |a CX3CR1 
653 |a medication 
653 |a diagnosis 
653 |a piccolo 
653 |a presynaptic cytomatrix protein 
653 |a medial prefrontal cortex 
653 |a dorsal striatum 
653 |a optogenetics 
653 |a social functioning 
653 |a n/a 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/4865  |7 0  |z Get Fullteks 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/78772  |7 0  |z DOAB: description of the publication